Dr. Jürgen Walkenhorst is leaving Life Science Nord

The Managing Director of Life Science Nord Management GmbH (LSN) is stepping down from his role for family reasons on December 31st, 2023

Dr. Jürgen Walkenhorst has been LSN Managing Director since June 1st, 2022 and is leaving the cluster due to family reasons at the end of 2023. On his departure from the cluster management, Dr. Walkenhorst expresses his thanks and appreciation to all cluster stakeholders, the board, and the management of Life Science Nord e.V. as well as the supervisory board for the constructive and trusting cooperation.

Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)
Dr. Jürgen Walkenhorst is stepping down as Managing Director of LSN on December 31st, 2023. (Image: Inga Sommer PHOTOGRAPHIE)

"It has been a great pleasure for me to work together with so many committed players from science, business and politics over the past year and a half on the further development of the life science sector in Schleswig-Holstein and Hamburg. Looking back on the experience I have gained from countless discussions, events and meetings, I am firmly convinced that the region is excellently positioned for the future thanks to its diverse strengths and exemplary willingness to cooperate. For me, this makes Life Science Nord one of the top clusters in Europe!"

Dr. Walkenhorst also emphasizes his personal thanks to the entire LSN team for their tireless efforts and comprehensive commitment.

"Every day, the team does a great job of promoting the life sciences sector in the North and giving the players and topics from the cluster visibility far beyond the region. I would like to thank everyone for the high level of positive energy and innovative spirit with which topics and challenges are tackled in the team."

Of course, the LSN team is there for all inquiries and topics as usual: The employees are available now and in the future under the known contact details.

Interim Management and Succession

The shareholders of Life Science Nord Management GmbH – the Free and Hanseatic City of Hamburg, the State of Schleswig-Holstein and Life Science Nord e.V. – are already in the process of finding a successor.

Maike Honold, Director Finance at LSN, will take over as interim Managing Director from January 1st, 2024 until a new Managing Director of LSN GmbH is appointed.

More News

To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …